Stefania Grimaudo

6.7k total citations · 1 hit paper
136 papers, 4.2k citations indexed

About

Stefania Grimaudo is a scholar working on Epidemiology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Stefania Grimaudo has authored 136 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Epidemiology, 40 papers in Organic Chemistry and 31 papers in Molecular Biology. Recurrent topics in Stefania Grimaudo's work include Liver Disease Diagnosis and Treatment (51 papers), Synthesis and biological activity (18 papers) and Hepatitis C virus research (18 papers). Stefania Grimaudo is often cited by papers focused on Liver Disease Diagnosis and Treatment (51 papers), Synthesis and biological activity (18 papers) and Hepatitis C virus research (18 papers). Stefania Grimaudo collaborates with scholars based in Italy, United States and Australia. Stefania Grimaudo's co-authors include Manlio Tolomeo, Rosaria Maria Pipitone, Salvatore Petta, Antonio Craxı̀, V. Di Marco, Daniele Simoni, Marinella Roberti, Antonietta Di Cristina, Calogero Cammà and Romeo Romagnoli and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Stefania Grimaudo

133 papers receiving 4.1k citations

Hit Papers

MAFLD: a multisystem disease 2023 2026 2024 2025 2023 25 50 75 100

Peers

Stefania Grimaudo
Stefania Grimaudo
Citations per year, relative to Stefania Grimaudo Stefania Grimaudo (= 1×) peers Urs P. Steinbrecher

Countries citing papers authored by Stefania Grimaudo

Since Specialization
Citations

This map shows the geographic impact of Stefania Grimaudo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefania Grimaudo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefania Grimaudo more than expected).

Fields of papers citing papers by Stefania Grimaudo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefania Grimaudo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefania Grimaudo. The network helps show where Stefania Grimaudo may publish in the future.

Co-authorship network of co-authors of Stefania Grimaudo

This figure shows the co-authorship network connecting the top 25 collaborators of Stefania Grimaudo. A scholar is included among the top collaborators of Stefania Grimaudo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefania Grimaudo. Stefania Grimaudo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pipitone, Rosaria Maria, et al.. (2023). MAFLD: a multisystem disease. Therapeutic Advances in Endocrinology and Metabolism. 14. 2435514829–2435514829. 118 indexed citations breakdown →
3.
Pipitone, Rosaria Maria, Ayesha Javed, Claudia La Mantia, et al.. (2023). Curcumin and Andrographolide Co-Administration Safely Prevent Steatosis Induction and ROS Production in HepG2 Cell Line. Molecules. 28(3). 1261–1261. 7 indexed citations
4.
Pipitone, Rosaria Maria, Stefania Grimaudo, Federica Spatola, et al.. (2021). A cholestatic pattern predicts liver outcomes in patients with nonalcoholic fatty liver disease. Digestive and Liver Disease. 53. S27–S27. 1 indexed citations
5.
Mazzucco, Walter, Velia Chiara Di Maio, F. Bronte, et al.. (2021). Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy. Journal of Hospital Infection. 115. 51–58. 5 indexed citations
6.
Cabibbo, Giuseppe, Ciro Celsa, Marco Enea, et al.. (2020). Optimizing Sequential Systemic Therapies for Advanced Hepatocellular Carcinoma: A Decision Analysis. Cancers. 12(8). 2132–2132. 16 indexed citations
7.
Amodio, Emanuele, Rosaria Maria Pipitone, Stefania Grimaudo, et al.. (2020). SARS-CoV-2 Viral Load, IFNλ Polymorphisms and the Course of COVID-19: An Observational Study. Journal of Clinical Medicine. 9(10). 3315–3315. 31 indexed citations
8.
Petta, Salvatore, Francesca Rini, Vincenza Calvaruso, et al.. (2019). Aminopyrine breath test predicts liver‐related events and death in HCV‐related cirrhosis on SVR after DAA therapy. Liver International. 40(3). 530–538. 1 indexed citations
9.
Pastore, Mirella, Stefania Grimaudo, Rosaria Maria Pipitone, et al.. (2019). Role of Myeloid-Epithelial-Reproductive Tyrosine Kinase and Macrophage Polarization in the Progression of Atherosclerotic Lesions Associated With Nonalcoholic Fatty Liver Disease. Frontiers in Pharmacology. 10. 604–604. 21 indexed citations
10.
Rondanin, Riccardo, Daniele Simoni, Romeo Romagnoli, et al.. (2017). Effects of Pimozide Derivatives on pSTAT5 in K562 Cells. ChemMedChem. 12(15). 1183–1190. 20 indexed citations
11.
Rondanin, Riccardo, Daniele Simoni, Romeo Romagnoli, et al.. (2014). Inhibition of activated STAT5 in Bcr/Abl expressing leukemia cells with new pimozide derivatives. Bioorganic & Medicinal Chemistry Letters. 24(18). 4568–4574. 23 indexed citations
12.
Petta, Salvatore, Luca Miele, Elisabetta Bugianesi, et al.. (2014). Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease. PLoS ONE. 9(2). e87523–e87523. 119 indexed citations
13.
Hribal, Marta Letizia, Teresa Procopio, Salvatore Petta, et al.. (2013). Insulin-Like Growth Factor-I, Inflammatory Proteins, and Fibrosis in Subjects With Nonalcoholic Fatty Liver Disease. The Journal of Clinical Endocrinology & Metabolism. 98(2). E304–E308. 74 indexed citations
14.
Petta, Salvatore, Luca Valenti, Giulio Marchesini, et al.. (2013). PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease. PLoS ONE. 8(9). e74089–e74089. 67 indexed citations
15.
Marco, V. Di, Vincenza Calvaruso, Stefania Grimaudo, et al.. (2012). Role of IL‐28B and inosine triphosphatase polymorphisms in efficacy and safety of Peg‐Interferon and ribavirin in chronic hepatitis C compensated cirrhosis with and without oesophageal varices. Journal of Viral Hepatitis. 20(2). 113–121. 13 indexed citations
16.
Milio, G, S. Siragusa, Alessandra Malato, Stefania Grimaudo, & António Pinto. (2009). Superficial venous thrombosis: role of inherited deficiency of natural anticoagulants in extension to deep veins.. PubMed. 28(4). 298–302. 7 indexed citations
17.
Romagnoli, Romeo, Pier Giovanni Baraldi, María Dora Carriòn, et al.. (2009). Design, synthesis and structure–activity relationship of 2-(3′,4′,5′-trimethoxybenzoyl)-benzo[b]furan derivatives as a novel class of inhibitors of tubulin polymerization. Bioorganic & Medicinal Chemistry. 17(19). 6862–6871. 69 indexed citations
18.
Milio, G, Sergio Siragusa, C Amato, et al.. (2008). Superficial venous thrombosis: Prevalence of common genetic risk factors and their role on spreading to deep veins. Thrombosis Research. 123(2). 194–199. 33 indexed citations
19.
D’Agostino, Pietro, Viviana Ferlazzo, Salvatore Milano, et al.. (2003). Chemically modified tetracyclines induce cytotoxic effects against J774 tumour cell line by activating the apoptotic pathway. International Immunopharmacology. 3(1). 63–73. 22 indexed citations
20.
Tolomeo, Manlio, Stefania Grimaudo, Salvatore Milano, et al.. (2002). Effects of chemically modified tetracyclines (CMTs) in sensitive, multidrug resistant and apoptosis resistant leukaemia cell lines. British Journal of Pharmacology. 135(6). 1588–1588.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026